Amphastar Pharmaceuticals (AMPH) Competitors $31.28 -0.02 (-0.06%) Closing price 04:00 PM EasternExtended Trading$31.28 +0.00 (+0.02%) As of 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AMPH vs. TLX, ELAN, LNTH, NUVL, CYTK, VRNA, GRFS, TGTX, KRYS, and SWTXShould you be buying Amphastar Pharmaceuticals stock or one of its competitors? The main competitors of Amphastar Pharmaceuticals include Telix Pharmaceuticals Limited American Depositary Shares (TLX), Elanco Animal Health (ELAN), Lantheus (LNTH), Nuvalent (NUVL), Cytokinetics (CYTK), Verona Pharma (VRNA), Grifols (GRFS), TG Therapeutics (TGTX), Krystal Biotech (KRYS), and SpringWorks Therapeutics (SWTX). These companies are all part of the "pharmaceutical products" industry. Amphastar Pharmaceuticals vs. Telix Pharmaceuticals Limited American Depositary Shares Elanco Animal Health Lantheus Nuvalent Cytokinetics Verona Pharma Grifols TG Therapeutics Krystal Biotech SpringWorks Therapeutics Amphastar Pharmaceuticals (NASDAQ:AMPH) and Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings. Do analysts prefer AMPH or TLX? Amphastar Pharmaceuticals presently has a consensus price target of $50.33, suggesting a potential upside of 60.81%. Telix Pharmaceuticals Limited American Depositary Shares has a consensus price target of $22.00, suggesting a potential upside of 26.36%. Given Amphastar Pharmaceuticals' higher probable upside, research analysts clearly believe Amphastar Pharmaceuticals is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amphastar Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Telix Pharmaceuticals Limited American Depositary Shares 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Do institutionals and insiders believe in AMPH or TLX? 65.1% of Amphastar Pharmaceuticals shares are owned by institutional investors. 27.1% of Amphastar Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is AMPH or TLX more profitable? Amphastar Pharmaceuticals has a net margin of 21.80% compared to Telix Pharmaceuticals Limited American Depositary Shares' net margin of 0.00%. Amphastar Pharmaceuticals' return on equity of 26.44% beat Telix Pharmaceuticals Limited American Depositary Shares' return on equity.Company Net Margins Return on Equity Return on Assets Amphastar Pharmaceuticals21.80% 26.44% 11.89% Telix Pharmaceuticals Limited American Depositary Shares N/A N/A N/A Which has higher valuation and earnings, AMPH or TLX? Amphastar Pharmaceuticals has higher revenue and earnings than Telix Pharmaceuticals Limited American Depositary Shares. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmphastar Pharmaceuticals$644.40M2.34$137.54M$3.0010.43Telix Pharmaceuticals Limited American Depositary SharesN/AN/AN/AN/AN/A Does the media refer more to AMPH or TLX? In the previous week, Amphastar Pharmaceuticals and Amphastar Pharmaceuticals both had 5 articles in the media. Amphastar Pharmaceuticals' average media sentiment score of 0.31 beat Telix Pharmaceuticals Limited American Depositary Shares' score of -0.05 indicating that Amphastar Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amphastar Pharmaceuticals 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Telix Pharmaceuticals Limited American Depositary Shares 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor AMPH or TLX? Amphastar Pharmaceuticals received 389 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 66.10% of users gave Amphastar Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAmphastar PharmaceuticalsOutperform Votes39266.10% Underperform Votes20133.90% Telix Pharmaceuticals Limited American Depositary SharesOutperform Votes3100.00% Underperform VotesNo Votes SummaryAmphastar Pharmaceuticals beats Telix Pharmaceuticals Limited American Depositary Shares on 9 of the 12 factors compared between the two stocks. Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMPH vs. The Competition Export to ExcelMetricAmphastar PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.50B$6.97B$5.80B$9.11BDividend YieldN/A2.88%5.28%3.98%P/E Ratio10.435.7725.2618.83Price / Sales2.34315.39473.04119.70Price / Cash7.0475.0445.1138.19Price / Book2.346.547.675.13Net Income$137.54M$138.11M$3.18B$245.96M7 Day Performance0.90%-0.74%-0.50%-0.89%1 Month Performance-13.13%-0.16%1.84%-0.51%1 Year Performance-38.93%-1.82%18.75%16.50% Amphastar Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMPHAmphastar Pharmaceuticals4.4315 of 5 stars$31.28-0.1%$50.33+60.9%-40.3%$1.50B$644.40M10.431,761TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$17.19-0.6%$22.00+28.0%N/A$5.79B$637.08M0.00N/ANews CoverageGap UpELANElanco Animal Health4.1542 of 5 stars$11.26-3.4%$16.29+44.7%-31.0%$5.57B$4.42B28.159,300Analyst ForecastLNTHLantheus4.588 of 5 stars$79.94-2.5%$131.86+64.9%+42.3%$5.56B$1.30B13.30700Analyst RevisionNUVLNuvalent1.8522 of 5 stars$77.93-3.7%$112.36+44.2%+0.5%$5.54BN/A-22.4640Upcoming EarningsInsider TradeCYTKCytokinetics4.2215 of 5 stars$46.16+10.9%$82.00+77.6%-33.5%$5.45B$7.53M-8.58250High Trading VolumeVRNAVerona Pharma1.9573 of 5 stars$64.21+4.1%$57.14-11.0%+277.6%$5.13B$460,000.00-33.4430GRFSGrifols2.1748 of 5 stars$7.32-2.0%N/A-11.8%$5.03B$7.13B6.2023,737TGTXTG Therapeutics4.4888 of 5 stars$30.71-0.1%$40.67+32.4%+133.9%$4.78B$233.66M-307.07290Positive NewsKRYSKrystal Biotech4.4939 of 5 stars$153.24-1.6%$206.67+34.9%+63.6%$4.41B$50.70M86.58210Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageSWTXSpringWorks Therapeutics1.2638 of 5 stars$57.43-2.0%$70.83+23.3%+22.8%$4.27B$5.45M-14.80230Earnings ReportAnalyst ForecastInsider TradeNews Coverage Related Companies and Tools Related Companies TLX Competitors ELAN Competitors LNTH Competitors NUVL Competitors CYTK Competitors VRNA Competitors GRFS Competitors TGTX Competitors KRYS Competitors SWTX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AMPH) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMPH Stock Alerts